Last Updated: January 19, 2017
Inception Date: 2000-04-05 00:00:00.0
Date Funded: 2009-08-28*
|Folio||S&P 500 Total Return|
(% of Folio)
|1||ALXN||alexion pharmaceuticals inc||3.33%|
|3||AVXS||avexis inc com||3.34%|
|4||AXON||axovant sciences ltd com||3.33%|
|6||BIO.B||bio rad labs inc cl b||3.33%|
|7||BMRN||biomarin pharmaceutical inc||3.33%|
|9||CBPO||china biologic prods inc com||3.33%|
|11||DBVT||dbv technologies s a sponsored adr||3.34%|
|12||EBS||emergent biosolutions inc com||3.33%|
|13||EXAS||exact sciences corp||3.33%|
|15||GILD||gilead sciences inc||3.34%|
|16||GLPG||galapagos nv spon adr||3.34%|
|17||HZNP||horizon pharma plc shs||3.33%|
|18||IART||integra lifesciences hldgs cp new||3.33%|
|19||ICPT||intercept pharmaceuticals inc com||3.34%|
|21||INCY||incyte genomics, inc||3.33%|
|22||LGND||ligand pharmaceuticals inc cl b||3.33%|
|23||LXRX||lexicon pharmaceuticals inc||3.34%|
|25||QGEN||qiagen n v ord||3.33%|
|26||RARE||ultragenyx pharmaceutical inc com||3.33%|
|28||SRPT||sarepta therapeutics inc new||3.34%|
|29||TECH||bio techne corp new||3.34%|
|30||VRTX||vertex pharmaceuticals inc||3.33%|
Steps to Create This Folio
- We selected securities with primary business operations in the Biotechnology industry, as defined by Zacks Investment Research.
- We ranked the securities according to market capitalization and selected 30 securities with the highest market capitalizations.
- We equally weighted all securities in the folio.
Number of Securities
There are generally 30 securities in the folio.
If the characteristics of the folio have changed substantially, the securities included may change. Also, corporate actions, such as a merger, or other events may cause changes to the securities held at any time. Your returns may deviate significantly from the values displayed here, due to many factors, including how long after a folio has been updated that you place orders to update your holdings.